GGrantIndex
Sort

59,101 grants matching hypertension

Genetic Testing (APOL1) Decisional Support for Potential Living Kidney Donors

$514,299
Heather Marie Gardiner · Temple Univ Of The Commonwealth · R01 · FY2021 · DK

The role ofglycosaminoglycan N-sulfation in glomerular biology/pathobiology

$514,289
Kevin John McCarthy · Louisiana State Univ Hsc Shreveport · R01 · FY2020 · DK

Tailored Hospital-based Risk Reduction to Impede Vascular Events after Stroke (TH

$514,243
Bruce Ovbiagele · Medical University Of South Carolina · U01 · FY2015 · NS

Tailored Hospital-based Risk Reduction to Impede Vascular Events after Stroke (TH

$514,243
Bruce Ovbiagele · Medical University Of South Carolina · U01 · FY2013 · NS

A Prospective, Multicenter Study to Develop Endoscopic, Histologic, Molecular, and Patient-reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Eosinophilic Gastritis

$514,209
Glenn T Furuta · Cincinnati Childrens Hosp Med Ctr · U54 · FY2016 · AI

Effect Of Iatrogenic Delivery at 34-38 Weeks' Gestation on Pregnancy Outcome

$514,195
David A Savitz · Women And Infants Hospital-Rhode Island · R01 · FY2015 · HD

Comparative Genomics of Glaucoma

$514,185
Robert R. H Anholt · North Carolina State University Raleigh · R01 · FY2008 · EY

Targeted tobacco regulatory science: Nicotine dose effects in animal models of smoking initiation in vulnerable adolescent subpopulations

$514,144
Mark G Lesage · Hennepin Healthcare Research Institute · R01 · FY2016 · DA

CLINICAL CORE

$514,131
Donald L. Bliwise · Emory University · P50 · FY2008 · AG

Common Inflammation Pathways between Aging and Hypertension That Weaken Bone

$514,125
David G Harrison · Vanderbilt University Medical Center · R01 · FY2023 · AG

Sleep and Cardiovascular Health

$514,084
Phyllis C Zee · Northwestern University At Chicago · R01 · FY2010 · HL

Glycopeptide vancomycin reshapes gut microbiota to mediate cardioprotective effects via microRNA-204

$514,072
Ajit Vikram · University Of Iowa · R01 · FY2024 · HL

A focus on alpha-1 blockade as a novel pharmacological treatment for alcohol use disorder

$514,069
Carolina Luisa Haass-Koffler · Brown University · R01 · FY2022 · AA

Molecular Physiology Core Applied to Acute Lung Injury

$514,028
Mark W Geraci · University Of Colorado Denver · P30 · FY2010 · HL

Mechanisms of mindfulness training to prevent hypertensive disorders of pregnancy

$514,011
Margaret Bublitz · Miriam Hospital · R01 · FY2022 · HL

Corazón de la Familia (Heart of the Family)

$514,007
Gia Mudd · University Of Kentucky · R01 · FY2020 · NR

Corazón de la Familia (Heart of the Family)

$514,007
Gia Mudd · University Of Kentucky · R01 · FY2019 · NR

Corazón de la Familia (Heart of the Family)

$514,007
Gia Mudd · University Of Kentucky · R01 · FY2021 · NR

Impact of Opiate abuse on HIV-mediated Pulmonary Vascular Remodeling

$513,994
Navneet Kaur Dhillon · University Of Kansas Medical Center · R01 · FY2016 · HL

TH and GTPCHI gene therapy for Parkinson's disease

$513,992
Jeffrey H Kordower · Rush University Medical Center · R01 · FY2010 · NS

HIV, Sleep, Nocturnal Non-dipping, and Cardiovascular Disease: a Tanzanian Cohort

$513,943
Robert N Peck · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · HL

Cognitive Decline in Chronic Renal Insufficiency

$513,915
Kristine Yaffe · Northern California Institute/Res/Edu · R01 · FY2009 · DK

Prediction of portal pressure with liver and spleen MR Elastography and 4D flow phase-contrast MRI

$513,907
Bachir Taouli · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · DK

Consortium Core

$513,868
Spero M Manson · Washington State University · U54 · FY2019 · MD

Functional Consequences of O2 Carrying Transfusion Toxicity

$513,841
Marcos Intaglietta · Albert Einstein College Of Medicine · P01 · FY2012 · HL